Moderna (MRNA) News Today

Moderna logo
$196.79 -10.01 (-4.84%)
Closing price 04:00 PM Eastern
Extended Trading
$195.18 -1.60 (-0.82%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is Moderna Dropping Today?

Moderna, Inc. (NASDAQ: MRNA) shares are under pressure amid a reported losing streak and concerns about the sustainability of the stock’s sharp rally. Recent updates also offer support for the company’s oncology pipeline, though analyst coverage remains cautious.

  • Positive Sentiment: Morgan Stanley said Moderna’s Phase 3 adjuvant melanoma results provide clinical proof of concept for its individualized treatment approach, strengthening the outlook for the oncology pipeline. Article
  • Positive Sentiment: Morgan Stanley raised its price target to $200 from $95, while maintaining an “equal weight” rating—a significant improvement in its valuation view, but not an outright bullish recommendation. Article
  • Neutral Sentiment: President Stephen Hoge reported sales of roughly 39,000 shares on each of November 16 and 17. Both transactions were made under a pre-arranged Rule 10b5-1 plan, which makes them less conclusive as a signal about management’s near-term outlook. SEC filing
  • Negative Sentiment: Recent coverage describes a prolonged decline following a roughly 600% year-to-date rally, raising the possibility of profit-taking and concerns that expectations for a recovery had become stretched. Article Article
  • Negative Sentiment: Some reports allege more adverse reactions with Moderna’s mRNA flu vaccine than with standard-dose flu shots. The cited VAERS reports do not, by themselves, establish that the vaccine caused those events, but the claims may add to investor concern about the product. Article
Posted 1h agoAI Generated. May Contain Errors.

Moderna Latest News

Best Biotech Stocks To Consider - November 18th
Moderna (NASDAQ:MRNA) Stock Falls 3.6% - What's Next?
Top Biotech Stocks To Consider - November 16th
Top Biotech Stocks To Add to Your Watchlist - November 15th
Moderna, Inc. (MRNA) - What Are Analysts Saying About This Stock?
Moderna, Inc. (MRNA) Analyst/Investor Day - Slideshow
Promising Biotech Stocks To Consider - November 13th
Brookline Capital Markets Forecasts Moderna FY2026 Earnings
The Next Chapter of mRNA
Moderna (NASDAQ:MRNA) Stock Falls 7% - Here's Why
Promising Biotech Stocks To Watch Today - November 12th
Why Moderna Stock Dropped on Thursday
Moderna Outlines Next Phase of Growth at Analyst Day
FY2029 EPS Forecast for Moderna Decreased by Analyst
Biotech Stocks To Research - November 11th
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom (MRNA)
AI infrastructure is being funded with debt and stock sales while biotech companies applying AI are booking revenue, led by Tempus AI, Recursion and iShares Biotechnology...
FY2026 EPS Estimate for Moderna Boosted by Analyst
Moderna (NASDAQ:MRNA) Shares Climb 5.8% Following Earnings Beat
Moderna (NASDAQ:MRNA) Shares Down 6.8% - Time to Sell?
Biotech Stocks To Research - November 10th
Why is Moderna (MRNA) stock soaring today
Moderna to Present at Upcoming Conference in November 2026
FY2029 EPS Estimate for Moderna Cut by Analyst

Moderna Media Mentions By Week

Moderna Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRNA
News Sentiment
▼
0.26

0.38
▲
Average
Healthcare
News Sentiment

Moderna News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRNA Articles
This Week
▼
33

9
▲
MRNA Articles
Average Week

Moderna Trends on MarketBeat

This week vs. last week
New Followers
6
+500%
Searches
6
-75%
Page Views
6,435
-21%
Get Moderna News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Moderna dated 11/18/2026.
From Our Partners